Why the study?
What are the current levels of cardiovascular disease prevention in rural India, and what is the potential impact of improved prevention strategies?
What are the current levels of cardiovascular disease prevention in rural India, and what is the potential impact of improved prevention strategies?
There are significant gaps in cardiovascular disease prevention in rural India, and implementing simple drug treatments for high-risk individuals could substantially reduce future cardiovascular burden.
Gaps in preventive therapy persist among high-risk rural Indians; leaves open whether modeled reductions would materialize in prospective studies.
OBJECTIVES: To determine levels of cardiovascular disease (CVD) prevention and to model the potential impact of improved prevention strategies for a large rural Indian region. DESIGN: A cross-sectional study with modelling of coronary heart disease (CHD) events over 10 years. SETTING: Rural Andhra Pradesh, India. PARTICIPANTS: A stratified random sample of 1,079 adults 30 years and older. MAIN OUTCOME MEASURES: Proportion on medical and behavioural treatments for prevention of CVD; estimated number of CHD events using a locally recalibrated Framingham risk equation. RESULTS: Among the 3.5% (95% CI 2.1% to 4.9%) with existing CVD, 49.3% (95% CI 28.8% to 69.8%) were on blood pressure (BP)-lowering medication, 4.7% (95% CI 0 to 10.4%) were on cholesterol-lowering medication, 24.6% (95% CI 9% to 40.3%) had increased exercise and 26.9% (95% CI 2.6% to 51.1%) attempted to quit smoking. Among the 7.6% (95% CI 6.2% to 8.9%) with a high global CHD risk (>20% over 10 years), 29.5% (95% CI 19.5 to 39.5%) were on BP-lowering medication, 2.8% (95% CI 0 to 6.7%) were on cholesterol-lowering medication, 19.4% (95% CI 10.9% to 28%) had increased exercise and 24.8% (95% CI 15.8% to 33.8%) attempted to quit smoking. If confirmed drug therapies were provided to all individuals at high risk there would be a 28% reduction in cardiovascular events over 10 years at an approximate annual treatment cost of US$533 per event avoided. CONCLUSIONS: There are serious deficiencies in CVD prevention in rural areas of India. Addressing these with simple confirmed drug treatments could produce a large reduction in the future cardiovascular burden in India.
No takes yet. Share an insight, caveat, or question.
Pell et al. (2011) studied this question.